Project description:We performed RNA sequencing on tumor samples from 12 glioblastoma patients to compare differences in gene expression between tumors

2022-09-01 | GSE211554 | GEO

Platelet miRNA expression in NSCLC patients

Project description:Gene expression profile of platelets have been explored due to their stability and abundance in plasma. In this study, we try to address the knowledge gap regarding liquid biopsy markers for early detection of non-small cell lung cancer (NSCLC). For that blood samples were collected in two time points, in the presence and absence of NSCLC. Platelets were isolated and miRNA expression evaluated by microarray technique.

2024-10-04 | GSE244646 | GEO

Platelet miRNA expression in NSCLC patients

Project description:Platelet miRNA expression in NSCLC patients

| PRJNA1023956 | ENA

c1851404-7747-4bac-a132-5f286f19478f - samples

Project description:Multi-region WES from 4 NSCLC patients, totaling 12 tumor samples and 4 matched control samples. The files were submitted as bam files.

| EGAD00001008382 | EGA

Plasma miRNA data from early NSCLC and HNSCC patients

Project description:Plasma miRNA data from early NSCLC and HNSCC patients

2024-10-04 | GSE244643 | GEO

RNA sequencing of tumor tissues from 12 glioblastoma patients

Project description:RNA sequencing of tumor tissues from 12 glioblastoma patients

| PRJNA870890 | ENA

microRNA microarray on a cohort study of platinum-sensitive versus platinum-resistant NSCLC patients

Project description:To identify microRNAs that regulate therapeutic resistance, we conducted a high-throughput miRNA microarray on a cohort study of primary NSCLC (non-small cell lung cancer) tissues and adjacent normal tissues. We found some microRNAs related to therapeutic resistance and poor prognosis. In this study, the patients who were diagnosed with resected NSCLC (adenocarcinoma or squamous cell carcinoma) were enrolled. All tumors were reviewed by pathologists and were pathologically diagnosed according to the World Health Organisation Classification of Tumors. Twenty-nine patients who received four or more courses of first-line platinum-based chemotherapy after postoperative recurrence were divided into two groups (responder (n=17) and non-responder group (n=12)). As identified by ANOVA analysis and quantitative RT-PCR (qRT-PCR) of 4 groups, some miRNAs exhibited significant expression changes.

2015-04-15 | E-GEOD-56036 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data